Aducanumab: una mirada dos años después de su aprobación
Biomédica (Bogotá); 44 (supl.1), 2024
Alzheimer’s disease is the leading cause of dementia worldwide and a critical public health problem. While deaths from cardiovascular diseases have decreased, those attributed to Alzheimer’s disease have increased in recent years with no curative treatment to date. In this context, effective treatmen...